Indigene is a next-generation
biopharmaceutical company with a unique two-pronged business
model to rapidly design, develop, and commercialize innovative,
safe, and effective healthcare products for the global Consumer Health Care (CHC) and Prescription (Rx) markets. Our product and business strategy has substantial time
and cost advantage as compared to new chemical entity based healthcare products.
Indigene has strong products and product pipelines targeting:
- Respiratory Disorders (>$15 Billion USD market)
- Diabetes and metabolic disorders (>$25 Billion USD market)
- Stress-related disorders and women's health (>$8 Billion USD market)
Indigene is seeking to expand its partnerships with alliances having
synergies and complimentary skills/resources who share our
vision and commitment. We bring substantial value to potential
partners for establishing "win-win" partnerships/collaborations. |